Market Cap: $3.55B
AI
Amylyx Pharmaceuticals, Inc.
AMLX
NASDAQ (NASDAQ Global Select)USD
Market Cap: $3.55B
Amylyx Pharmaceuticals: Leading the Charge in Innovative Therapies for Unmet Medical Needs Amylyx Pharmaceuticals, Inc. is stepping into the spotlight with its upcoming presentation at the Oppenheimer…
Amylyx Pharmaceuticals Launches Public Offering to Support Innovative Treatments Amylyx Pharmaceuticals, Inc., based in Cambridge, Massachusetts, announces the initiation of an underwritten public off…
Amylyx Pharmaceuticals Drives Forward with Public Offering to Enhance Pipeline and Commercialization Efforts Amylyx Pharmaceuticals, based in Cambridge, Massachusetts, announces a significant public o…
Amylyx Pharmaceuticals to Showcase Innovations in Neurodegenerative Disease Treatments at Upcoming Health Conference Amylyx Pharmaceuticals, Inc., a Cambridge-based company dedicated to addressing hig…
Amylyx Pharmaceuticals Prepares for Q3 2024 Financial Results Announcement Amylyx Pharmaceuticals, a pioneering biotechnology firm based in Cambridge, Massachusetts, gears up to release its financial…